| 000 | 00989 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514071128.0 | ||
| 264 | 0 | _c20030721 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a1369-7056 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMucke, Hermann A M | |
| 245 | 0 | 0 |
_aCEP-1347 (Cephalon). _h[electronic resource] |
| 260 |
_bIDrugs : the investigational drugs journal _cApr 2003 |
||
| 300 |
_a377-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarbazoles _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aContraindications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xadverse effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadverse effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 773 | 0 |
_tIDrugs : the investigational drugs journal _gvol. 6 _gno. 4 _gp. 377-83 |
|
| 999 |
_c12574805 _d12574805 |
||